Ronald Nahass, MD, MHCM,FIDSA

Ronald Nahass, MD, MHCM,FIDSA

Infectious Disease in Hillsborough, NJ


 (908) 281-0221

Contact


Hide Show

Office Hours

Monday:
9:00 am - 5:00 pm
Tuesday:
9:00 am - 5:00 pm
Wednesday:
9:00 am - 5:00 pm
Thursday:
9:00 am - 5:00 pm
Friday:
9:00 am - 5:00 pm
Saturday:
Closed
Sunday:
Closed

Hide Show

Additional Locations


10 Forestal Road,
Suite 203,
Princeton, NJ

81 Veronica Avenue,
Somerset, NJ

█████  ████  ███
▄▄  ▄▄  ▄▄▄▄  ▄▄  ▄▄▄▄
▄▄▄  ▄▄▄▄  ▄▄▄▄  ▄▄ 
Hide Show

About Dr. Nahass


Dr. Ronald Nahass, MD is an infectious disease specialist in Hillsborough, New Jersey. He is currently licensed to practice medicine in New Jersey. He is affiliated with University Med Center Princeton, Robert Wood Johnson University Hospital, and Saint Peter's University Hospital.

Hide Show

Services Offered



Hepatitis B
Hepatitis C
HIV/AIDS
Fever of unknown origin
Anti Virals - Hepatitis C and HIV
Diagnostic Dilemna

Qualifications and Experience



Hide Show

Education & Training

Harvard University School of Public Health
MHCM, Healthcare Leadership, 2010 - 2012

UMDNJ-Robert Wood Johnson Medical School
Residency, Internal Medicine, 1982 - 1986

Rutgers Robert Wood Johnson Medical School
Class of 1982

Rensselaer Polytechnic Institute
B.S., Cum Laude, 1979

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Certifications

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

NJ State Medical License
1983 - 2019

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Work Experience


Id Associates
Hillsborough, NJ
2010 - Present

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Hospital Affiliations

ID CARE
Current Affiliation

Robert Wood Johnson University Hospital Somerset
Current Affiliation
Somerville, NJ

Morristown Medical Center
Current Affiliation
Morristown, NJ

Saint Peter's University Hospital
Current Affiliation
New Brunswick, NJ

East Mountain Hospital
Current Affiliation
Belle Mead, NJ

Robert Wood Johnson University Hospital
Current Affiliation
New Brunswick, NJ

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Top Doctors: New York Metro Area
Castle Connolly

.Special commendation for self directed learning
American Medical Association

Distguished Attending
Robert Wood Johnson University Hospital

New York Magazine: Top Doctors
Castle Connolly, 2010-2016

America's Top Doctors
Castle Connolly, 2002-2016

Physicians Recognition Award with Special Commendation
AMA, 2015

Legend In Medicine Award
Smith Foundation for Infectious Diseases, 2015

Medical Guide to Best Doctors Northeast region and National Best Doctor in America
Castle, Connolly, 2014

Top 1% Physician In US Recognition
US News and World Report, 2014

Inside Jersey Magazine Top Doctors
Castle Connolly, 2009-2014

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Professional Memberships

Infectious Disease Society of America - IDSA
Fellow

American College of Physician Executives - ACPE
Member

American College of Physicians - ACP
Fellow

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older.
Gerontol Geriatr Med
Flamm, S.,Peng, C. Y.,Shibolet, O.,Nahass, R.,Hwang, P.,Barr, E.,Robertson, M. N.,Haber, B. A.
3/21/2019

The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Brunetti, L., Lee, S., Nahass, R. G., Suh, D., Miao, B., Bucek, J., Kim, D., Kim, O., Suh, D.
11/6/2018

How Do You Measure Up: Quality Measurement for Improving Patient Care and Establishing the Value of Infectious Diseases Specialists.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Eby, J. C., Lane, M. A., Horberg, M., Gentry, C. N., Coffin, S. E., Ray, A. J., Sheridan, K. R., Bratzler, D. W., Wheeler, D., Sarumi, M., Barlam, T. F., Kim, T. J., Rodriguez, A., Nahass, R. G.
9/27/2018

See All

Journal Article

Thorn-Induced Alternaria septic arthritis and osteomyelitis of the hand
Infect Dis Clin Practice
Li Boning, Boretz R, Nahass RG
1/1/2016

Linkage to Care for Hepatitis C Virus (HCV) Among Suburban Heroin Users in New Jersey
Emerg Infect Dis
Akyar E, Seneca KH, Akyar S, Schoefield N, Schwartz MP, Nahass RG
1/1/2016

Implications of baseline HCVRNA level and intrapatient viral load variability on OBV/PTV/R + DSV 12-week treatment outcomes
Journal of Hepatology
Brown RS, Puoti M, Cooper C, Wyles DL, Sepe TE, Nahass RG, et al
1/1/2015

Lecture

Infectious Disease Physicians and the Future of Healthcare
1/1/2015

HIV/HCV Coinfection
1/1/2015

Hepatitits C in Clinical Practice
1/1/2015
San Diego, CA

Abstract

C-EDGE CO-STAR: Risk of Reinfection Following Successful Therapy with Elbasvir and Grazoprevir in Persons who Inject Drugs (PWID) Receiving Opioid Agonist Therapy (OAT)
EASL
Dore GJ, Altice F, Litwin AH, Grebely J, Dalgard O, Gane E, Shibolet O, Luetkemeyer A, Nahass R, et al
1/1/2016
Barcelona, Spain

High efficacy of sofosbuvir/velpatasvir plus gs-9857 for 12 weeks in treatment-experienced genotype 1-6 hcv-infected patients, including those previously treated with direct-acting antivirals
EASL
Lawitz E, Kowdley K, Curry M, Reau N, Nguyen M, Kwo P, Jacobson I, Tran T, Nahass RG
1/1/2016
Barcelona, Spain

Sofosbuvir + PEGInterferon/Ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experineced cirrhotic patients with genotype 2 HCV: The Boson Study
EASL
Foster GR, Pianko S, Cooper C, Brown A, Forton D, Nahass RG, et al
1/1/2015
Vienna, Austria

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Press Mentions



High Efficacy with Sofosbuvir/Velpatasvir + Voxilaprevir for Pangenotypic HCV
Monthly Prescribing Reference · October 29, 2016
...ell tolerated, and highly effective in treatment-naive and treatment-experienced patients, reported Ronald Nahass, MD, FIDSA, FSHEA, from ID Care, Inc., Hillsborough, NJ, at IDWeek 2016. Sofosbuvir is a nucleotide...

Dangerous Strain of Hepatitis Striking Suburban Heroin Users
NJ.com · April 13, 2016
...ose with hepatitis were far more likely to have a more aggressive strain of the virus, according to Ronald G. Nahass, an infectious disease specialist with ID Care, a Hillsborough-based practice. Hepatitis C3 is more...

AMA Wire®: What It’s like to Be in Infectious Disease: Shadowing Dr. Nahass
AMA Wire · October 26, 2015
...er what it’s like to be an infectious disease (ID) specialist? Here’s your chance to find out. Meet Ronald G. Nahass, MD, an ID specialist and featured physician in AMA Wire’s® “Shadow Me” Specialty Series, which off...